IonQ reported a 755% revenue increase to $64.67 million in Q1 2026 but faces significant losses with negative cash flow and heavy stock dilution. The company is aggressively expanding quantum capabilities through deals and national projects but remains reliant on equity funding. IBM, by contrast, posted $15.92 billion revenue with steady growth and strong free cash flow, funding quantum research internally without shareholder dilution. Investors seeking quantum exposure face a choice between IonQ's high-risk growth and IBM's stable, self-funded approach. The key test for IonQ will be converting its performance obligations into cash before needing more capital.
IonQ, a leading quantum computing stock, surged on strong Q1 2026 revenue and contracts but faces heavy losses and cash burn, making it a risky single-stock bet. The Defiance Quantum ETF (QTUM) offers broader exposure across 85 quantum and AI hardwar...
Investor enthusiasm for quantum computing is evolving from broad speculation to selective investment based on commercial progress. Over the past six months, IonQ has outperformed other pure-play quantum companies by securing government contracts, par...
President Trump signed two executive orders to accelerate quantum computing development and prepare for security risks from quantum technology. This federal push includes billions in funding, benefiting companies like IBM, D-Wave, Rigetti, and IonQ, ...
